Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

China flag China · Delayed Price · Currency is CNY
4.980
+0.210 (4.40%)
Jul 27, 2026, 3:00 PM CST
Market Cap2.61B -19.9%
Revenue (ttm)332.27M +0.2%
Net Income-98.32M
EPS-0.16
Shares Out 524.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume18,409,300
Open4.750
Previous Close4.770
Day's Range4.620 - 5.020
52-Week Range4.190 - 7.700
Beta0.12
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHA:600538

Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, distributes pharmaceutical products in China. It operates through Pharmaceutical Distribution; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails pharmaceutical products through hospitals, clinics, other medical institutions, pharmacies, health centers, clinics, directly operated stores, general agents, distributors, and allocations. It also provides pearl eye drops, pearl powde... [Read more]

Sector Materials
Founded 1993
Employees 438
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600538
Full Company Profile

Financial Performance

In 2025, SHA:600538's revenue was 328.24 million, a decrease of -3.59% compared to the previous year's 340.47 million. Losses were -87.62 million, -6.64% less than in 2024.

Financial Statements